Skip to content

Comparition the impact of Steroid and intraarticular ozon on improving the symptoms of osteoarthritis of knee

Comparition the impact of intraarticular Steroid and intraarticular ozon on improving the symptoms of osteoarthritis of knee

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100827004641N18
Enrollment
40
Registered
2021-11-17
Start date
2019-09-23
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

????? ?????? ???? ????. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: In the ozone therapy group, 5 cc of ozone with a concentration of 30 micrograms per ml with 2 cc of 2% lidocaine will be injected into the joint. Ozone injections w

Sponsors

Physical Medicibe and Rehabilitaion Research Center of Tabriz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: Moderate Knee Osteoarthritis (grade two or three based Radiographic classification (Kellegren and Lawrence) Existence of symptoms in favor of Knee Osteoarthritis for at least 3 months Minimum score of 3 in the criterion (VAS) Absence of Inflammatory Rheumatic diseases 45 years old and older Satisfaction of patients participating in the study Failure to respond to Conservative drug treatments and physiotherapy lasted for 6 months

Exclusion criteria

Exclusion criteria: Severe Osteoarthritis (grade 4 candidates for joint replacement surgery) Rheumatic disease Clearly Visible deformity of the knee Ankylosis Contraindications to Ozone include: Hyperthyroidism , Thrombocytopenia ,Pregnancy , Recent heart attack history ,G6PD Deficiency Definitive and partial Contraindications to Steroid injection include: Bacteremia, Sepsis, Intra articular or pre uricular infection, History of post injection Allergy, Intra articular or Osteochondral fracture at the injection site, Severe Joint destruction in Injection site , Artificial joint , Uncontrolled Coagulation disorders Specific skin lesion at the injection site

Design outcomes

Primary

MeasureTime frame
The amount af Reduce in pain after injection. Timepoint: Immediately before injection and 1 month after injection and 6 months after injection. Method of measurement: Western Ontario and McMaster Universities Arthritis Index (WOMAC)questionare.

Secondary

MeasureTime frame
Improvement of function of Knee. Timepoint: Immediately before injection and one and six months after injection. Method of measurement: Western Ontario and McMaster Universities Arthritis Index (WOMAC)questionare.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bina Eftekharsadat

Tabriz University of Medical Sciences

Binasadat@gmail.com+98 41 3337 6923

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026